Verona Pharma NASDAQ VRNA
$15.47 0.0000 0.0000%
Today share price
UK
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 18 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

1.24B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

1.02B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

0.51
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

80.27M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-22.18 %
Upcoming events Verona Pharma All events
No upcoming events scheduled

Stock chart Verona Pharma

Stock analysis Verona Pharma

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-22.79 34.97
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
4.98 13.28
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-15.57 17.35
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
3.39 0.36
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-21.86 9.48

Price change Verona Pharma per year

4.45$ 9.72$
Min Max

Summary analysis Verona Pharma

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Verona Pharma

Revenue and net income Verona Pharma

All parameters

About company Verona Pharma

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. Its product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 2 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. It also focuses on developing ensifentrine for the treatment of COVID-19. Verona Pharma plc was founded in 2005 and is headquartered in London, the United Kingdom.
Address:
3 More London Riverside, London, United Kingdom, SE1 2RE
Company name: Verona Pharma
Issuer ticker: VRNA
ISIN: US9250501064
Country: UK
Exchange: NASDAQ
Currency: $
IPO date: 2017-04-27
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.veronapharma.com

On which stock exchange are Verona Pharma (VRNA) stocks traded?

Verona Pharma (VRNA) stocks are traded on NASDAQ.

What is the ticker of Verona Pharma stocks (VRNA)?

The stock ticker of Verona Pharma’s stocks or in other words, the code is VRNA. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Verona Pharma (VRNA) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Verona Pharma (VRNA) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Verona Pharma (VRNA) stocks traded?

Verona Pharma (VRNA) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Verona Pharma (VRNA) stocks today?

The current price of Verona Pharma stocks on 29.04.2024 is 15.47 dollars. per share.

What is the dynamics of Verona Pharma (VRNA) stocks from the beginning of the year?

Verona Pharma (VRNA) quotes have increased by -17.76% from the beginning of the year up to 15.47 dollars. per 1 stocks.

How much did Verona Pharma (VRNA) stocks increase in апреле 2024?

This month Verona Pharma (VRNA) quotes have increased by -3.61% to 15.47 dollars. per share.

How much are Verona Pharma (VRNA) stocks worth?

Today, on October, 29.04.2024 Verona Pharma’s (VRNA) stocks cost 15.47 dollars..

What is the market capitalization of Verona Pharma (VRNA)?

Capitalization is the market value of Verona Pharma (VRNA) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 29.04.2024, the market capitalization of Verona Pharma (VRNA) is estimated at about 1241736693 dollars.